• Curaleaf Holdings (CURA) has been granted final approval to open its adult-use dispensary in Ware, Massachusetts
  • The approval marks the company’s third adult-use location in the state, with locations already operational in Oxford and Princetown
  • Curaleaf is the largest cannabis company in the US in terms of operational capacity, with 53 dispensaries across the country
  • Shares in the company are currently down 1.77 per cent to C$8.87, with a market cap of C$4.17 billion

Curaleaf Holdings (CURA) has been granted final license approval for its adult-use retail dispensary in Ware, Massachusetts.

The approval marks the company’s third Massachusetts-based adult-use location, with existing dispensaries in Oxford and Princetown.

“Providing high quality and reliable products to patients and customers in our home state of Massachusetts is a big part of our company’s strategy,” said Curaleaf CEO, Joseph Lusardi. 

“We’re excited to be opening our third adult-use dispensary here in the Commonwealth of Massachusetts.”

Headquartered in Wakefield, Curaleaf is the largest cannabis operator in the United States in terms of operational and wholesale footprint, with 53 dispensaries currently active nation-wide.

“We will be adding more than twenty new jobs to the local economy and we look forward to building an impactful, positive relationship with the community,” said Curaleaf Massachusetts President, Patrik Jonsson.

“We feel very honored to be bringing our business to Ware, located in the Hampshire County and the greater Springfield area.”

Earlier this month, Curaleaf announced the acquisition of Cura Partners Inc., owner of the popular Select brand, in a deal that “marks an unprecedented phase of growth for our company,” Mr. Lusardi said at the time.

Curaleaf shares are currently down 1.77 per cent to C$8.87, with a market cap of C$4.17 billion.

More From The Market Online
Cannabis Report image of farmed cannabis plants

The Market Online’s Weekly Cannabis Report – July 26, 2024

Tilray Oral Solution THC10:CBD10 cannabis extract, aka Tilray Solução Oral THC10:CBD10, has been approved for medical use in Portugal.
medical branch logo

Tilray approved for third medical cannabis product in Portugal

Tilray Medical, a subsidiary of Tilray Brands (TSX:TLRY) has been approved for a new medical cannabis extract in Portugal.